Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9671)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 27, 2015 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Azmi AN, Tan SS, Mohamed R. Hepatitis C and kidney disease: An overview and approach to management. World J Hepatol 2015; 7(1): 78-92 [PMID: 25624999 DOI: 10.4254/wjh.v7.i1.78] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i1/78.htm |
| Number | Citing Articles |
| 1 |
Sofija Sekulic, Zeljko Mijailovic, Dejan Petrovic, Ruzica Lukic, Marina Jovanovic, Ivan Jovanovic. HCV Infection and Chronic Renal Disease. Serbian Journal of Experimental and Clinical Research 2021; 0(0) doi: 10.2478/sjecr-2021-0010
|
| 2 |
Diana L. Shuster, Rajeev M. Menon, Bifeng Ding, Amit Khatri, Hong Li, Eric Cohen, Melissa Jewett, Daniel E. Cohen, Jiuhong Zha. Effects of chronic kidney disease stage 4, end-stage renal disease, or dialysis on the plasma concentrations of ombitasvir, paritaprevir, ritonavir, and dasabuvir in patients with chronic HCV infection: pharmacokinetic analysis of the phase 3 RUBY-I and RUBY-II trials. European Journal of Clinical Pharmacology 2019; 75(2): 207 doi: 10.1007/s00228-018-2566-6
|
| 3 |
Howayda Abd Elhameed Elshinnawy, Iman Ibrahim Sarhan, Ossama Ashraf Ahmed, Meryhan Osama Mohamed, Cherry Reda Kamel. Study the response of Qurevo (ombitasvir, paritaprevir, and ritonavir) in end-stage renal disease patients with hepatitis C virus. Egyptian Liver Journal 2022; 12(1) doi: 10.1186/s43066-022-00196-x
|
| 4 |
Anita Kohli, Ali Alshati, Fawaz Georgie, Richard Manch, Robert G. Gish. Direct-acting antivirals for the treatment of chronic hepatitis C in patients with chronic kidney disease. Therapeutic Advances in Gastroenterology 2016; 9(6): 887 doi: 10.1177/1756283X16665254
|
| 5 |
Gde Somayana, Komang Agus Wira Nugraha. Hepatitis C - Recent Advances. 2023; doi: 10.5772/intechopen.1001052
|
| 6 |
Saba Khaliq, Syed Raza. Current Status of Direct Acting Antiviral Agents against Hepatitis C Virus Infection in Pakistan. Medicina 2018; 54(5): 80 doi: 10.3390/medicina54050080
|
| 7 |
Sébastien Dharancy, Audrey Coilly, Claire Fougerou-Leurent, Christophe Duvoux, Nassim Kamar, Vincent Leroy, Albert Tran, Pauline Houssel-Debry, Valérie Canva, Christophe Moreno, Filoména Conti, Jérome Dumortier, Vincent Di Martino, Sylvie Radenne, Victor De Ledinghen, Louis D’Alteroche, Christine Silvain, Camille Besch, Philippe Perré, Danielle Botta-Fridlund, Claire Francoz, François Habersetzer, Hélène Montialoux, Armand Abergel, Maryline Debette-Gratien, Alexandra Rohel, Emilie Rossignol, Didier Samuel, Jean-Charles Duclos-Vallée, Georges-Philippe Pageaux. Direct-acting antiviral agent–based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study. American Journal of Transplantation 2017; 17(11): 2869 doi: 10.1111/ajt.14490
|
| 8 |
Elena Laura Iliescu, Adriana Mercan-Stanciu, Letitia Toma. Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease. BMC Nephrology 2020; 21(1) doi: 10.1186/s12882-020-1687-1
|
| 9 |
Mohamed Gendia, Pietro Lampertico, Carlo Maria Alfieri, Roberta D'Ambrosio, Maria Teresa Gandolfo, Maria Rosaria Campise, Fabrizio Fabrizi, Piergiorgio Messa. Impact of hepatitis C virus and direct acting antivirals on kidney recipients: a retrospective study. Transplant International 2019; 32(5): 493 doi: 10.1111/tri.13393
|
| 10 |
Nerissa George, AnnMarie Liapakis, Kevin M. Korenblat, Tingting Li, David Roth, Jerry Yee, Kevin J. Fowler, Lehman Howard, Jingxia Liu, Mary C. Politi. A Patient Decision Support Tool for Hepatitis C Virus and CKD Treatment. Kidney Medicine 2019; 1(4): 200 doi: 10.1016/j.xkme.2019.06.003
|
| 11 |
Zyad Hussein J. AL-Qaisi, Alaa Hussein J. AL-Qaisi, Wessal M. Khamis, Zaman Ahmed Hussein, Iman Rajab Mohammed. The transmission risk factors of hepatitis B and C infection in dental treating and tattooing among hemodialysis patients. Research Journal of Pharmacy and Technology 2023; : 418 doi: 10.52711/0974-360X.2023.00071
|
| 12 |
Adeera Levin, Marcello Tonelli, Joseph Bonventre, Josef Coresh, Jo-Ann Donner, Agnes B Fogo, Caroline S Fox, Ron T Gansevoort, Hiddo J L Heerspink, Meg Jardine, Bertram Kasiske, Anna Köttgen, Matthias Kretzler, Andrew S Levey, Valerie A Luyckx, Ravindra Mehta, Orson Moe, Gregorio Obrador, Neesh Pannu, Chirag R Parikh, Vlado Perkovic, Carol Pollock, Peter Stenvinkel, Katherine R Tuttle, David C Wheeler, Kai-Uwe Eckardt, Dwomoa Adu, Sanjay Kumar Agarwal, Mona Alrukhaimi, Hans-Joachim Anders, Gloria Ashuntantang, Shakti Basnet, Aminu K. Bello, Worawon Chailimpamontree, Ricardo Correa-Rotter, Jonathan Craig, Walter G. Douthat, Harold I. Feldman, Mohammad Reza Ganji, Guillermo Garcia-Garcia, Mohammed Benghanem Gharbi, David C. Harris, Vivekanand Jha, David W. Johnson, Rumeyza Kazancioglu, Robyn Langham, Zhi-Hong Liu, Ziad A. Massy, Masaomi Nangaku, Robert G. Nelson, Donal O'Donoghue, Ikechi Okpechi, Roberto Pecoits-Filho, Neil R. Powe, Giuseppe Remuzzi, Charlotte Roberts, Jerome Rossert, Laura Sola, Benedicte Stengel, Ernest K. Sumaili M, Yusuke Suzuki, Tetsuhiro Tanaka, Sajja Tatiyanupanwong, Bernadette Thomas, Katrin Uhlig, Robert Walker, Sarah L. White, Andrzej Wiecek, Chih-Wei Yang. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. The Lancet 2017; 390(10105): 1888 doi: 10.1016/S0140-6736(17)30788-2
|
| 13 |
Juan Berenguer, Elena Rodríguez‐Castellano, Ana Carrero, Miguel A. Von Wichmann, Marta Montero, María J. Galindo, Josep Mallolas, Manuel Crespo, María J. Téllez, Carmen Quereda, José Sanz, Carlos Barros, Cristina Tural, Ignacio Santos, Federico Pulido, Josep M. Guardiola, Rafael Rubio, Enrique Ortega, María L. Montes, Juan J. Jusdado, Gabriel Gaspar, Herminia Esteban, José M. Bellón, Juan González‐García. Eradication of hepatitis C virus and non‐liver‐related non–acquired immune deficiency syndrome–related events in human immunodeficiency virus/hepatitis C virus coinfection. Hepatology 2017; 66(2): 344 doi: 10.1002/hep.29071
|
| 14 |
Dilek BULUT, Merve Sefa SAYAR, Ali ACAR. The effect of direct-acting antivirals (DAA) on confirmed noninvasive fibrous parameters in chronic hepatitis C patients. Anatolian Current Medical Journal 2023; 5(4): 426 doi: 10.38053/acmj.1343277
|
| 15 |
M. C. Politi, N. George, T. Li, K. M. Korenblat, K. J. Fowler, C. Ho, A. Liapakis, D. Roth, J. Yee. Project HELP: a study protocol to pilot test a shared decision-making tool about treatment options for patients with hepatitis C and chronic kidney disease. Pilot and Feasibility Studies 2018; 4(1) doi: 10.1186/s40814-018-0251-2
|
| 16 |
M. Berenguer, K. Agarwal, P. Burra, M. Manns, D. Samuel. The road map toward an hepatitis C virus-free transplant population. American Journal of Transplantation 2018; 18(10): 2409 doi: 10.1111/ajt.14976
|
| 17 |
Yi-Chun Chen, Chung-Yi Li, Shiang-Jiun Tsai, Yen-Chun Chen. Anti-hepatitis C virus therapy in chronic kidney disease patients improves long-term renal and patient survivals. World Journal of Clinical Cases 2019; 7(11): 1270-1281 doi: 10.12998/wjcc.v7.i11.1270
|
| 18 |
Khulood T Ahmed, Ashraf A Almashhrawi, Jamal A Ibdah, Veysel Tahan. Is the 25-year hepatitis C marathon coming to an end to declare victory?. World Journal of Hepatology 2017; 9(21): 921-929 doi: 10.4254/wjh.v9.i21.921
|
| 19 |
Jonathan Wang, Christopher Poon, Deborah Chin, Sarah Milkowski, Vivian Lu, Kenneth R. Hallows, Eun Ji Chung. Design and in vivo characterization of kidney-targeting multimodal micelles for renal drug delivery. Nano Research 2018; 11(10): 5584 doi: 10.1007/s12274-018-2100-2
|
| 20 |
Sandra Beinhardt, Ramona Al Zoairy, Peter Ferenci, Karin Kozbial, Clarissa Freissmuth, Rafael Stern, Albert Friedrich Stättermayer, Rudolf Stauber, Michael Strasser, Heinz Zoller, Bruno Watschinger, Alice Schmidt, Michael Trauner, Harald Hofer, Andreas Maieron. DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and postkidney transplantation setting. Transplant International 2016; 29(9): 999 doi: 10.1111/tri.12799
|
| 21 |
Claudia Cottone, Kalyan Ram Bhamidimarri. Evaluating CKD/ESRD patient with hepatitis C infection: How to interpret diagnostic testing and assess liver injury. Seminars in Dialysis 2019; 32(2): 119 doi: 10.1111/sdi.12760
|
| 22 |
Ruzica Lukic, Nevena Gajovic, Ivan Jovanovic, Milena Jurisevic, Zeljko Mijailovic, Veljko Maric, Biljana Popovska Jovicic, Nebojsa Arsenijevic. Potential Hepatoprotective Role of Galectin-3 during HCV Infection in End-Stage Renal Disease Patients. Disease Markers 2017; 2017: 1 doi: 10.1155/2017/6275987
|
| 23 |
Reza Alizadeh, Ziba Aghsaie Fard. Renal impairment and analgesia: From effectiveness to adverse effects. Journal of Cellular Physiology 2019; 234(10): 17205 doi: 10.1002/jcp.28506
|
| 24 |
Valerie A. Luyckx, Katherine R. Tuttle, Guillermo Garcia-Garcia, Mohammed Benghanem Gharbi, Hiddo J.L. Heerspink, David W. Johnson, Zhi-Hong Liu, Ziad A. Massy, Orson Moe, Robert G. Nelson, Laura Sola, David C. Wheeler, Sarah L. White. Reducing major risk factors for chronic kidney disease. Kidney International Supplements 2017; 7(2): 71 doi: 10.1016/j.kisu.2017.07.003
|
| 25 |
Haesuk Park, Chao Chen, Wei Wang, Linda Henry, Robert L. Cook, David R. Nelson. Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD. Hepatology 2018; 67(2): 492 doi: 10.1002/hep.29505
|
| 26 |
Manik Kataruka, Shefali Gupta, Raja Ramchandran, Mini Singh, Radha Krishan Dhiman, Kishan Lal Gupta. Incidence and Risk Factors for Hepatitis C Virus and Hepatitis B Virus Seroconversion in End-Stage Renal Failure Patients on Maintenance Hemodialysis. Journal of Clinical and Experimental Hepatology 2020; 10(4): 316 doi: 10.1016/j.jceh.2019.11.002
|
| 27 |
Ahmed Yahia Elmowafy, Mohamed Hamed Abbas, Ahmed Abdelfattah Denewar, Mohamed Elsayed Mashaly, Gamal Shiha, Salwa Mahmoud El Wasif, Lionel Rostaing, Mohamed Adel Bakr. The effect of anemia on the efficacy and safety of treating chronic hepatitis C infection with direct-acting antivirals in patients with chronic kidney disease. International Urology and Nephrology 2021; 53(4): 749 doi: 10.1007/s11255-020-02656-y
|
| 28 |
Mabel Michille Kimble, Marjan Javanbakht, Kara W. Chew, Chrysovalantis Stafylis, Di He, Samantha Ramirez, Yeonsoo Baik, Sammy Saab, Jeffrey D. Klausner. Sociodemographic and clinical characteristics of persons who experienced spontaneous hepatitis C viral clearance. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4223-9
|
| 29 |
Vicente Soriano, Juan Berenguer. Extrahepatic comorbidities associated with hepatitis C virus in HIV-infected patients. Current Opinion in HIV and AIDS 2015; 10(5): 309 doi: 10.1097/COH.0000000000000175
|
| 30 |
Aude Desnoyer, Dan Pospai, Minh Patrick Lê, Anne Gervais, Alexandra Heurgué-Berlot, Achour Laradi, Stanislas Harent, Adriana Pinto, Dominique Salmon, Sophie Hillaire, Hélène Fontaine, David Zucman, Anne-Marie Simonpoli, Patrice Muret, Lucile Larrouy, Brigitte Bernard Chabert, Diane Descamps, Yazdan Yazdanpanah, Gilles Peytavin. Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C. Journal of Hepatology 2016; 65(1): 40 doi: 10.1016/j.jhep.2016.02.044
|
| 31 |
Luis Falcato, Simone Temperli, Philip Bruggmann, Franz Immer. Impact of the direct acting antivirals on chronic hepatitis C prevalence on the Swiss organ transplantation list: a retrospective analysis. Exploration of Digestive Diseases 2023; 2(6): 297 doi: 10.37349/edd.2023.00032
|
| 32 |
Lucija Kuna, Jelena Jakab, Robert Smolic, George Y Wu, Martina Smolic. HCV Extrahepatic Manifestations. Journal of Clinical and Translational Hepatology 2019; 7(X): 1 doi: 10.14218/JCTH.2018.00049
|
| 33 |
Joichi Usui, Takashi Tawara-Iida, Kenji Takada, Itaru Ebihara, Atsushi Ueda, Satoshi Iwabuchi, Takashi Ishizu, Tadashi Iitsuka, Katsumi Takemura, Tetsuya Kawamura, Shuzo Kaneko, Kentaro Sakai, Hirayasu Kai, Tomoka Gomibuchi, Michio Nagata, Masaki Kobayashi, Akio Koyama, Machi Suka, Jai Radhakrishnan, Kunihiro Yamagata, Yoshitaka Isaka. Temporal Changes in Post-Infectious Glomerulonephritis in Japan (1976-2009). PLOS ONE 2016; 11(6): e0157356 doi: 10.1371/journal.pone.0157356
|
| 34 |
Salamat Ali, Tofeeq Ur-Rehman, Eleri Lougher, David Mutimer, Mashhood Ali, Vibhu Paudyal. Impact of HIV and chronic kidney disease comorbidities on hepatitis C treatment choices, drug–drug interactions and hepatitis C cure. International Journal of Clinical Pharmacy 2020; 42(2): 515 doi: 10.1007/s11096-020-00994-6
|
| 35 |
Luis Falcato, Simone Temperli, Philip Bruggmann, Franz Immer. Impact of the direct acting antivirals on chronic hepatitis C prevalence on the Swiss organ transplantation list: a retrospective analysis. Exploration of Digestive Diseases 2023; 2(6): 297 doi: 10.37349/edd.2023.00032
|
| 36 |
Nancy Reau, Paul Y. Kwo, Susan Rhee, Robert S. Brown, Kosh Agarwal, Peter Angus, Edward Gane, Jia‐Horng Kao, Parvez S. Mantry, David Mutimer, K. Rajender Reddy, Tram T. Tran, Yiran B. Hu, Abhishek Gulati, Preethi Krishnan, Emily O. Dumas, Ariel Porcalla, Nancy S. Shulman, Wei Liu, Suvajit Samanta, Roger Trinh, Xavier Forns. Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection. Hepatology 2018; 68(4): 1298 doi: 10.1002/hep.30046
|
| 37 |
|
| 38 |
Kati Kaartinen, Sauli Vuoti, Eero Honkanen, Eliisa Löyttyniemi, Ravinder Singh, Martti Färkkilä, Chen-Hua Liu. Tubular cell damage may be the earliest sign of renal extrahepatic manifestation caused by Hepatitis C. PLOS ONE 2021; 16(5): e0251392 doi: 10.1371/journal.pone.0251392
|